Good Manufacturing Practice (GMP) Services For Cell And Gene Therapy Market Report Infographic Image

Published : February 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Good Manufacturing Practice (GMP) Services For Cell And Gene Therapy Market Report 2026

Name: Good Manufacturing Practice (GMP) Services For Cell And Gene Therapy Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Service Type (Process Development, Manufacturing, Analytical and Quality Control, Fill-Finish, Other Service Types), By Therapy Type (Cell Therapy, Gene Therapy, Combination Therapy), By Phase (Preclinical, Clinical, Commercial), By End-User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Good Manufacturing Practice (GMP) Services For Cell And Gene Therapy Market Overview

• Good Manufacturing Practice (GMP) Services For Cell And Gene Therapy market size has reached to $2.49 billion in 2025

• Expected to grow to $5.88 billion in 2030 at a compound annual growth rate (CAGR) of 18.9%

• Growth Driver: Increasing Number Of Cell And Gene Therapy Clinical Trials Fueling The Growth Of The Market Due To Expanding Demand For Compliant Manufacturing Support

• Market Trend: Expansion Of Advanced Cell Therapy Manufacturing Capabilities To Support Clinical Development

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Good Manufacturing Practice (GMP) Services For Cell And Gene Therapy Market?

Good manufacturing practice (GMP) services for cell and gene therapy refer to regulated manufacturing and quality-control activities that ensure cell- and gene-based therapies are produced safely, consistently, and in compliance with global regulatory standards. These services include GMP-compliant facilities, cell and viral vector processing, testing, documentation, and regulatory support for clinical and commercial use.

The main service types of good manufacturing practice (GMP) services for cell and gene therapy include process development, manufacturing, analytical and quality control, fill-finish, and other service types. Process development refers to the design, optimization, and scale-up of cell and gene therapy production processes to ensure consistency, safety, and regulatory compliance. These services are applied across therapy types including cell therapy, gene therapy, and combination therapy, and phases including preclinical, clinical, and commercial. They are used by end users including pharmaceutical and biotechnology companies, academic and research institutes, and other end users.

Good Manufacturing Practice (GMP) Services For Cell And Gene Therapy Market Report bar graph

What Is The Good Manufacturing Practice (GMP) Services For Cell And Gene Therapy Market Size and Share 2026?

The good manufacturing practice (gmp) services for cell and gene therapy market size has grown rapidly in recent years. It will grow from $2.49 billion in 2025 to $2.95 billion in 2026 at a compound annual growth rate (CAGR) of 18.6%. The growth in the historic period can be attributed to growth in clinical trials for advanced therapies, expansion of cell therapy research programs, increasing regulatory standardization, development of early-stage gmp facilities, rising investment in biopharmaceutical manufacturing.

What Is The Good Manufacturing Practice (GMP) Services For Cell And Gene Therapy Market Growth Forecast?

The good manufacturing practice (gmp) services for cell and gene therapy market size is expected to see rapid growth in the next few years. It will grow to $5.88 billion in 2030 at a compound annual growth rate (CAGR) of 18.9%. The growth in the forecast period can be attributed to increasing commercialization of gene therapies, rising demand for scalable manufacturing capacity, expansion of personalized medicine pipelines, growing outsourcing to cdmos, increasing adoption of automated quality control systems. Major trends in the forecast period include increasing demand for commercial-scale cell and gene therapy manufacturing, rising adoption of viral vector production services, growing focus on gmp-compliant automation, expansion of fill-finish and cold chain services, enhanced emphasis on regulatory compliance.

Book your 30 minutes free consultation with our research experts

Global Good Manufacturing Practice (GMP) Services For Cell And Gene Therapy Market Segmentation

1) By Service Type: Process Development; Manufacturing; Analytical and Quality Control; Fill-Finish; Other Service Types

2) By Therapy Type: Cell Therapy; Gene Therapy; Combination Therapy

3) By Phase: Preclinical; Clinical; Commercial

4) By End-User: Pharmaceutical and Biotechnology Companies; Academic and Research Institutes; Other End-Users

Subsegments:

1) By Process Development: Vector Design Optimization; Cell Line Development; Upstream Process Optimization; Downstream Purification Development; Process Scale Up Studies

2) By Manufacturing: Clinical Trial Material Production; Commercial Scale Manufacturing; Viral Vector Manufacturing; Plasmid Production Services; Cell Therapy Manufacturing

3) By Analytical and Quality Control: Method Development And Validation; Potency And Efficacy Testing; Safety And Sterility Testing; Stability And Shelf Life Studies; Release Testing Services

4) By Fill-Finish: Aseptic Filling Services; Vial And Syringe Filling; Lyophilization Services; Packaging And Labeling; Cold Chain Handling

5) By Other Service Types: Regulatory Support Services; Technology Transfer Services; Supply Chain Management; Storage And Distribution; Post Manufacturing Support

What Is The Driver Of The Good Manufacturing Practice (GMP) Services For Cell And Gene Therapy Market?

The increasing number of cell and gene therapy clinical trials is expected to propel the growth of the good manufacturing practice (GMP) services for cell and gene therapy market going forward. Cell and gene therapy trials are regulated studies evaluating the safety, efficacy, and quality of advanced therapies that use genetically modified cells or living cells to treat conditions such as cancer, rare genetic disorders, and autoimmune diseases. The growth in these trials is being fueled by expanded research and development in advanced therapies, increased investment from biotechnology and pharmaceutical companies, and rising demand for innovative treatments for unmet medical needs. As many trial sponsors lack in-house GMP manufacturing capabilities, they increasingly rely on specialized GMP service providers for compliant manufacturing, analytical testing, quality control, and quality assurance. These services are critical to ensuring the safe, consistent, and timely supply of clinical-grade materials across trial phases. For instance, in January 2026, according to Bioindustry Association (BIA) a UK-based national trade association, the UK had 193 ongoing advanced therapy clinical trials, with over half in early stages and more than 80% focused on gene therapies. Therefore, the increasing number of cell and gene therapy clinical trials is driving the growth of the good manufacturing practice (GMP) services for cell and gene therapy industry.

Key Players In The Global Good Manufacturing Practice (GMP) Services For Cell And Gene Therapy Market

Major companies operating in the good manufacturing practice (gmp) services for cell and gene therapy market are Novartis AG, Boehringer Ingelheim BioXcellence GmbH, Batavia Biosciences B.V., FUJIFILM Diosynth Biotechnologies, AGC Biologics Inc., Lonza Group AG, WuXi AppTec Co. Ltd., BioNTech Innovative Manufacturing Services, Charles River Laboratories International Inc., Catalent Inc., Samsung Biologics Co. Ltd., Miltenyi Biotec GmbH, SK pharmteco Co. Ltd., KBI Biopharma Inc., Oxford Biomedica plc, OmniaBio Inc., RoslinCT Ltd., Pluri CDMO, SCTbio Inc., Made Scientific Inc., ENCell Co. Ltd.

Global Good Manufacturing Practice (GMP) Services For Cell And Gene Therapy Market Trends and Insights

Major companies operating in the good manufacturing practice (GMP) services for cell and gene therapy market are increasingly focused on expanding advanced manufacturing capabilities, including cell therapy manufacturing, to support regional clinical trials and accelerate therapy development. Cell therapy manufacturing involves GMP-compliant processes for the collection, modification, expansion, and formulation of therapeutic cells to ensure product safety, quality, and clinical effectiveness. For instance, in July 2025, AGC Biologics, a US-based contract development and manufacturing organization (CDMO), launched cell therapy process development and clinical manufacturing services at its Yokohama Technical Center in Japan. The facility supports GMP-compliant production for preclinical and clinical trials, including CAR-T therapies, induced pluripotent stem cells, and other stem cell platforms. This expansion strengthens AGC Biologics’ global GMP footprint across Europe, North America, and Asia, enabling faster and more compliant advancement of cell and gene therapies toward commercialization.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Good Manufacturing Practice (GMP) Services For Cell And Gene Therapy Market?

In May 2025, Altaris LLC, a US-based healthcare investment firm, acquired Minaris Regenerative Medicine GmbH for an undisclosed amount. Through this acquisition, Altaris, LLC aims to expand its global GMP capabilities in cell and gene therapy by integrating Minaris Regenerative Medicine’s expertise in compliant manufacturing of advanced therapy products. Minaris Regenerative Medicine GmbH is a Germany-based contract development and manufacturing organization (CDMO) specializing in GMP-compliant cell and gene therapy manufacturing.

Regional Insights

North America was the largest region in the good manufacturing practice (GMP) services for cell and gene therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Good Manufacturing Practice (GMP) Services For Cell And Gene Therapy Market?

The good manufacturing practice (GMP) services for cell and gene therapy market includes revenues earned by entities through clinical manufacturing support, commercial scale manufacturing support, fill-finish services, cell banking services, raw material management services, quality control testing services, analytical testing services, regulatory support services, and quality assurance and compliance services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Good Manufacturing Practice (GMP) Services For Cell And Gene Therapy Market Report 2026?

The good manufacturing practice (gmp) services for cell and gene therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the good manufacturing practice (gmp) services for cell and gene therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Good Manufacturing Practice (GMP) Services For Cell And Gene Therapy Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$2.95 billion
Revenue Forecast In 2035	$5.88 billion
Growth Rate	CAGR of 18.6% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Service Type, Therapy Type, Phase, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Novartis AG, Boehringer Ingelheim BioXcellence GmbH, Batavia Biosciences B.V., FUJIFILM Diosynth Biotechnologies, AGC Biologics Inc., Lonza Group AG, WuXi AppTec Co. Ltd., BioNTech Innovative Manufacturing Services, Charles River Laboratories International Inc., Catalent Inc., Samsung Biologics Co. Ltd., Miltenyi Biotec GmbH, SK pharmteco Co. Ltd., KBI Biopharma Inc., Oxford Biomedica plc, OmniaBio Inc., RoslinCT Ltd., Pluri CDMO, SCTbio Inc., Made Scientific Inc., ENCell Co. Ltd.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Industry 4.0 & Intelligent Manufacturing

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Sustainability, Climate Tech & Circular Economy

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Demand For Commercial-Scale Cell And Gene Therapy Manufacturing

4.2.2 Rising Adoption Of Viral Vector Production Services

4.2.3 Growing Focus On Gmp-Compliant Automation

4.2.4 Expansion Of Fill-Finish And Cold Chain Services

4.2.5 Enhanced Emphasis On Regulatory Compliance

5. Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Analysis Of End Use Industries

5.1 Pharmaceutical Companies

5.2 Biotechnology Companies

5.3 Cell Therapy Developers

5.4 Gene Therapy Developers

5.5 Contract Development And Manufacturing Organizations (Cdmos)

6. Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Size, Comparisons And Growth Rate Analysis

7.3. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Segmentation

9.1. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Process Development, Manufacturing, Analytical and Quality Control, Fill-Finish, Other Service Types

9.2. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cell Therapy, Gene Therapy, Combination Therapy

9.3. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Preclinical, Clinical, Commercial

9.4. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Other End-Users

9.5. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Sub-Segmentation Of Process Development, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Vector Design Optimization, Cell Line Development, Upstream Process Optimization, Downstream Purification Development, Process Scale Up Studies

9.6. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Sub-Segmentation Of Manufacturing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Clinical Trial Material Production, Commercial Scale Manufacturing, Viral Vector Manufacturing, Plasmid Production Services, Cell Therapy Manufacturing

9.7. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Sub-Segmentation Of Analytical and Quality Control, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Method Development And Validation, Potency And Efficacy Testing, Safety And Sterility Testing, Stability And Shelf Life Studies, Release Testing Services

9.8. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Sub-Segmentation Of Fill-Finish, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Aseptic Filling Services, Vial And Syringe Filling, Lyophilization Services, Packaging And Labeling, Cold Chain Handling

9.9. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Sub-Segmentation Of Other Service Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Regulatory Support Services, Technology Transfer Services, Supply Chain Management, Storage And Distribution, Post Manufacturing Support

10. Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Regional And Country Analysis

10.1. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market

11.1. Asia-Pacific Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market

12.1. China Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market

13.1. India Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market

14.1. Japan Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Overview

14.2. Japan Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market

15.1. Australia Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market

16.1. Indonesia Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market

17.1. South Korea Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Overview

17.2. South Korea Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market

18.1. Taiwan Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Overview

18.2. Taiwan Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market

19.1. South East Asia Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Overview

19.2. South East Asia Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market

20.1. Western Europe Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Overview

20.2. Western Europe Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market

21.1. UK Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market

22.1. Germany Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market

23.1. France Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market

24.1. Italy Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market

25.1. Spain Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market

26.1. Eastern Europe Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Overview

26.2. Eastern Europe Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market

27.1. Russia Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market

28.1. North America Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Overview

28.2. North America Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market

29.1. USA Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Overview

29.2. USA Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market

30.1. Canada Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Overview

30.2. Canada Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market

31.1. South America Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Overview

31.2. South America Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market

32.1. Brazil Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market

33.1. Middle East Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Overview

33.2. Middle East Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market

34.1. Africa Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Overview

34.2. Africa Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Regulatory and Investment Landscape

36. Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Competitive Landscape And Company Profiles

36.1. Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Company Profiles

36.3.1. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Boehringer Ingelheim BioXcellence GmbH Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Batavia Biosciences B.V. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. FUJIFILM Diosynth Biotechnologies Overview, Products and Services, Strategy and Financial Analysis

36.3.5. AGC Biologics Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Other Major And Innovative Companies

Lonza Group AG, WuXi AppTec Co. Ltd., BioNTech Innovative Manufacturing Services, Charles River Laboratories International Inc., Catalent Inc., Samsung Biologics Co. Ltd., Miltenyi Biotec GmbH, SK pharmteco Co. Ltd., KBI Biopharma Inc., Oxford Biomedica plc, OmniaBio Inc., RoslinCT Ltd., Pluri CDMO, SCTbio Inc., Made Scientific Inc.

38. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market

41. Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market High Potential Countries, Segments and Strategies

41.1 Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market In 2030 - Countries Offering Most New Opportunities

41.2 Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market In 2030 - Segments Offering Most New Opportunities

41.3 Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market In 2030 - Growth Strategies

41.3.1 Market Trend Based Strategies

41.3.2 Competitor Strategies

42. Appendix

42.1. Abbreviations

42.2. Currencies

42.3. Historic And Forecast Inflation Rates

42.4. Research Inquiries

42.5. The Business Research Company

42.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Overview Of Key Products - Product Examples

Table 2: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Supply Chain Analysis

Table 4: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Major Raw Material Providers

Table 5: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Major Resource Providers

Table 6: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Major Manufacturers (Suppliers)

Table 7: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Major Distributors And Channel Partners

Table 8: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Key Technologies & Future Trends

Table 9: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Major Trends

Table 10: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Major End Users

Table 11: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market - TAM, US$ Billion, 2025

Table 15: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Sub-Segmentation Of Process Development, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Sub-Segmentation Of Manufacturing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Sub-Segmentation Of Analytical and Quality Control, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Sub-Segmentation Of Fill-Finish, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Sub-Segmentation Of Other Service Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia , Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia , Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia , Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 99: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market - Company Scoring Matrix

Table 100: Upcoming Startups

Table 101: Novartis AG Financial Performance

Table 102: Boehringer Ingelheim BioXcellence GmbH Financial Performance

Table 103: Batavia Biosciences B.V. Financial Performance

Table 104: FUJIFILM Diosynth Biotechnologies Financial Performance

Table 105: AGC Biologics Inc. Financial Performance

Table 106: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Competitive Benchmarking (In USD Billions)

Table 107: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Competitive Dashboard

Table 108: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 109: Global, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Size Gain ($ Billion), Segmentation By Service Type, 2025 – 2030

Table 110: Global, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Size Gain ($ Billion), Segmentation By Therapy Type, 2025 – 2030

Table 111: Global, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Size Gain ($ Billion), Segmentation By Phase, 2025 – 2030

List Of Figures

Figure 1: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Overview Of Key Products - Product Examples

Figure 2: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Supply Chain Analysis

Figure 4: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Major Raw Material Providers

Figure 5: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Major Resource Providers

Figure 6: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Major Manufacturers (Suppliers)

Figure 7: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Major Distributors And Channel Partners

Figure 8: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Key Technologies & Future Trends

Figure 9: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Major Trends

Figure 10: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Major End Users

Figure 11: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market - TAM, US$ Billion, 2025

Figure 15: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Sub-Segmentation Of Process Development, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Sub-Segmentation Of Manufacturing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Sub-Segmentation Of Analytical and Quality Control, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Sub-Segmentation Of Fill-Finish, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Sub-Segmentation Of Other Service Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia , Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia , Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia , Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 99: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market - Company Scoring Matrix

Figure 100: Upcoming Startups

Figure 101: Novartis AG Financial Performance

Figure 102: Boehringer Ingelheim BioXcellence GmbH Financial Performance

Figure 103: Batavia Biosciences B.V. Financial Performance

Figure 104: FUJIFILM Diosynth Biotechnologies Financial Performance

Figure 105: AGC Biologics Inc. Financial Performance

Figure 106: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Competitive Benchmarking (In USD Billions)

Figure 107: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Competitive Dashboard

Figure 108: Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 109: Global, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Size Gain ($ Billion), Segmentation By Service Type, 2025 – 2030

Figure 110: Global, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Size Gain ($ Billion), Segmentation By Therapy Type, 2025 – 2030

Figure 111: Global, Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Size Gain ($ Billion), Segmentation By Phase, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

GMP Cell Therapy Consumables Market Report 2026 - Global Outlook – By Product (Kits, Reagents Or Molecular Biology Reagents, Growth Factors Or Cytokines And Interleukins, Other Products), By Cell Therapy (NK Cell Therapy...

Cell And Gene Therapy Supply Chain/Logistics Market Report 2026 - Global Outlook – By Type Of Software Solution (Cell Orchestration Platform, Enterprise Manufacturing System, Inventory Management System, Laboratory Infor...

Cell And Gene Therapy Clinical Trial Services Market Report 2026 - Global Outlook – By Service (Clinical Trial Design And Planning, Supply And Logistic Services, Regulatory Affairs And Compliance, Data Management And Bio...

Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Report 2026 - Global Outlook – By Product Type (Gene Therapy, Gene-Modified Cell Therapy, Cell Therapy), By Phase (Phase 1, Phase 2,...

Gene Therapy Market Report 2026 - Global Outlook – By Gene Therapy Type (Germline Therapy, Somatic Cell Therapy), By Vector (Viral Vector, Non-Viral Vector), By Application (Oncology, Orphan Disease, Knee Osteoarthritis,...

Stem Cell Manufacturing Market Report 2026 - Global Outlook – By Product (Consumables, Instruments, Stem Cell Lines), By Application (Research Applications, Clinical Application, Cell And Tissue Banking Applications), By...

Biopharmaceuticals Contract Manufacturing Market Report 2026 - Global Outlook – By Product (Biologics, Monoclonal Antibodies (MABs), Recombinant Proteins, Vaccines, Antisense, RNAI, And Molecular Therapy, Biosimilars), B...

Frequently Asked Questions

How big is the Good Manufacturing Practice (GMP) Services For Cell And Gene Therapy Market?

The Good Manufacturing Practice (GMP) Services For Cell And Gene Therapy market was valued at $2.49 billion in 2025, increased to $2.95 billion in 2026, and is projected to reach $5.88 billion by 2030.

What is the Good Manufacturing Practice (GMP) Services For Cell And Gene Therapy market growth?

The global Good Manufacturing Practice (GMP) Services For Cell And Gene Therapy market is expected to grow at a CAGR of 18.9% from 2026 to 2035 to reach $5.88 billion by 2035.

Who are the key players in Good Manufacturing Practice (GMP) Services For Cell And Gene Therapy market?

Some Key Players in the Good Manufacturing Practice (GMP) Services For Cell And Gene Therapy market Include, Novartis AG, Boehringer Ingelheim BioXcellence GmbH, Batavia Biosciences B.V., FUJIFILM Diosynth Biotechnologies, AGC Biologics Inc., Lonza Group AG, WuXi AppTec Co. Ltd., BioNTech Innovative Manufacturing Services, Charles River Laboratories International Inc., Catalent Inc., Samsung Biologics Co. Ltd., Miltenyi Biotec GmbH, SK pharmteco Co. Ltd., KBI Biopharma Inc., Oxford Biomedica plc, OmniaBio Inc., RoslinCT Ltd., Pluri CDMO, SCTbio Inc., Made Scientific Inc., ENCell Co. Ltd. .

What is the anticipated growth trend for the Good Manufacturing Practice (GMP) Services For Cell And Gene Therapy market?

Major trend in this market includes: Expansion Of Advanced Cell Therapy Manufacturing Capabilities To Support Clinical Development. For further insights on this market. request a sample here

Which region has the most growth potential in the Good Manufacturing Practice (GMP) Services For Cell And Gene Therapy market?

North America was the largest region in the good manufacturing practice (GMP) services for cell and gene therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the good manufacturing practice (gmp) services for cell and gene therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.